Identify and isolate rare antigen-specific B cells from large heterogeneous populations in just two days.

Global research efforts to identify and develop new therapeutics have stressed the need for speed and efficiency in the antibody discovery and development process. The discovery of therapeutic antibodies relies on the deep interrogation of whole B cell repertoires or hybridoma populations. Yet, screening efforts are time-consuming and costly using traditional methods.

Read our new application note for a robust and rapid single B cell screening method to identify antibodies of desired antigenic specificity without the laborious need for traditional hybridoma screening. Using this method, researchers can identify antibody-secreting cells and isolate rare cells secreting antigen-specific antibodies in just two days, significantly accelerating the time to market for therapeutics.